Aurora Innovation has just reported results with shorts partially rebuilding after last week's pre-earnings retreat — the key question now is whether that covering was a temporary pause or a genuine change in conviction.
Short interest came into earnings week at 11.4% of the free float, down from a one-month high but still elevated. The data tells a clear two-act story. Heading into the July 29 print, shorts covered sharply — positions fell roughly 8% in the July 23-24 sessions, dropping from above 196 million shares to around 179 million. Since then, they have quietly crept back. By July 28, short interest edged up 1.3% in a single day, recovering to 182 million shares. Over the full month, the position has grown about 9%, so the pre-earnings covering looks more like tactical exposure management than a shift in view. The borrow market remains unconstrained: availability is running at 207% of shares short — meaning there are roughly two shares available to borrow for every one already borrowed — and has tightened notably from 295% just three weeks ago, though it remains well within normal territory. Cost to borrow ticked up 20% on the week to 0.64%, still low in absolute terms. Squeeze mechanics are absent.
Options positioning offers a mild contrarian read against the short-interest story. The put/call ratio edged higher to 0.19, about 1.7 standard deviations above its 20-day mean — the most defensive it has been in recent weeks — but the absolute level remains among the lowest readings of the past year. The 52-week low on PCR is 0.12; the high is 0.42. The market leans call-heavy relative to history, which has been the consistent posture for AUR throughout 2026. The slight uptick in put demand is a marginal caution signal, not a positioning reversal.
The Street is split but tilts positive. Five buy-equivalent ratings sit against a handful of hold calls, with a consensus mean target of $11.22 — roughly 80% above the current $6.21 price. That target gap has compressed meaningfully from over 100% upside at the start of the year, as the stock has rallied. The most recent formal analyst action came from Cantor Fitzgerald, which reiterated Overweight with a $12 target on July 23. The bull case rests on Aurora Driver commercialisation in Class 8 trucking, 50%-plus hardware cost reductions in the second-generation kit, and an expected path to gross profit positivity by late 2026. The bear case is simpler: revenue is minimal — $1 million in Q3 2025 — and the safety-and-public-trust overhang on autonomous vehicles has slowed adoption timelines. Goldman Sachs sits at Neutral with a $5 target, a meaningful discount to where the stock trades today. The ORTEX short score is running at 67.8 out of 100, in the bottom decile for short-score rank among tracked names, signalling that the data composite still flags this as a heavily-scrutinised short candidate.
The ownership picture adds one notable data point worth flagging. Uber trimmed its stake by 67.5 million shares in early June at $7.10 — a $479 million disposal that reduced its holding from roughly 16% to 13% of the company. That sale came at a 14% premium to where the stock trades now, and it represents the single largest insider transaction in the recent window. Against that, director David Wehner bought $498,000 of stock at $6.04 in mid-June. The net 90-day insider flow is positive in share terms only because of a technical reclassification; the economically meaningful signal is Uber's continued distribution of its position. T. Rowe Price remains the largest institutional holder at 15% of shares, and added 17 million shares in the quarter ending June 30, partially absorbing the Uber supply.
With earnings now released — today's event was the catalyst that defined the pre-earnings positioning story — the narrative shifts to how the market digests the print and whether the short-interest rebuild since July 24 accelerates or reverses in the sessions ahead.
See the live data behind this article on ORTEX.
Open AUR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
